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ABSTRACT: Pseudoachondroplasia(PSACH)resultsfrom
mutations in cartilage oligomeric matrix protein (COMP)
and the p.D469del mutation within the type III repeats
of COMP accounts for approximately 30% of PSACH.
To determine disease mechanisms of PSACH in vivo, we
introduced the Comp D469del mutation into the mouse
genome. Mutant animals were normal at birth but grew
slower than their wild-type littermates and developed
short-limb dwarﬁsm. In the growth plates of mutant mice
chondrocyte columns were reduced in number and poorly
organized, while mutant COMP was retained within the
endoplasmic reticulum (ER) of cells. Chondrocyte prolif-
eration was reduced and apoptosis was both increased and
spatially dysregulated. Previous studies on COMP mu-
tations have shown mutant COMP is co-localized with
chaperone proteins, and we have reported an unfolded
protein response (UPR) in mouse models of PSACH-
MED (multiple epiphyseal dysplasia) harboring mutations
in Comp (T585M) and Matn3, Comp etc (V194D). How-
ever, we found no evidence of UPR in this mouse model
of PSACH. In contrast, microarray analysis identiﬁed ex-
pression changes in groups of genes implicated in oxida-
tive stress, cell cycle regulation, and apoptosis, which is
consistent with the chondrocyte pathology. Overall, these
data suggest that a novel form of chondrocyte stress trig-
gered by the expression of mutant COMP is central to the
pathogenesis of PSACH.
Hum Mutat 33:218–231, 2012. C  2011 Wiley Periodicals, Inc.
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Introduction
Pseudoachondroplasia (PSACH; MIM# 177170) is an autoso-
mal dominant disease that affects skeletal development and has a
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clinical spectrum ranging from mild to severe [Maroteaux et al.,
1980; Rimoin et al., 1994; Wynne-Davies et al., 1986]. The dis-
ease results almost exclusively from mutations in the gene encod-
ing cartilage oligomeric matrix protein (COMP; MIM# 600310)
[Briggs and Chapman, 2002; Briggs et al., 1995; Hecht et al., 1995],
a 550-kDa extracellular matrix (ECM) glycoprotein found in car-
tilage, tendon, and ligament [DiCesare et al., 1994; Hecht et al.,
1998; Oldberg et al., 1992]. Mutations in COMP can also result
in a related chondrodysplasia, multiple epiphyseal dysplasia (MED;
MIM# 132400), which is a clinically variable and genetically het-
erogeneous disease that can also result from mutations in the genes
encoding matrilin-3 (MATN3; MIM# 602109) and type IX collagen
(COL9A1; MIM# 120210, COL9A2; MIM# 120260, and COL9A3;
MIM# 120270) [Briggs and Chapman, 2002; Chapman et al., 2001;
Muragaki et al., 1996; Paassilta et al., 1999].
COMP is thought to be important for ECM assembly within the
cartilage growth plate by acting as a catalyst in the regulation of
collagen ﬁbril assembly [Halasz et al., 2007; Rosenberg et al., 1998],
as well as interacting with other ECM proteins such as members of
the matrilin protein family [Fresquet et al., 2007; Mann et al., 2004]
andtypeIXcollagen [Holdenet al.,2001;Thuret al.,2001].COMP
has also been shown to be central to the integrity of chondrocytes
withintheECM.Intheﬁrstinstance,itisimportantintheregulation
of chondrocyte attachment to the ECM through integrin receptors
[Chen et al., 2005; Rock et al., 2010]. Second, COMP plays an
important regulatory role in chondrocyte proliferation [Xu et al.,
2007] and has recently been proposed to have a cell survival role
by promoting the upregulation of inhibitors of apoptosis proteins
(IAPs), particularly XIAP, cIAP1, cIAP2, and survivin [Gagarina
et al., 2008]. Overall, these studies have suggested an important
function for COMP in the regulation and maintenance of cell–
matrix integrity within the cartilage growth plate.
It was therefore surprising that a knockout mouse model of
COMPdisplayednoovertskeletalphenotype[Svenssonetal.,2002],
whichsupportsthehypothesisthatthecompromisedskeletaldevel-
opment in PSACH and MED results from antimorphic (dominant
negative) COMP mutations [Briggs and Chapman, 2002].
COMP is a modular protein and comprises an N-terminal
oligomerization domain, four epidermal growth factor-like (TSP2)
repeats, eight calcium binding type 3 (TSP3) repeats, and a C-
terminal globular domain. An increasing number of mutations
(∼15%) have been reported in the C-terminal domain of COMP
[Kennedy et al., 2005b]; however, the majority of PSACH and MED
mutations (85%) are clustered in the TSP3 repeats [Kennedy et al.,
2005a].Themostcommondisease-causingmutationisthein-frame
deletionofanasparticacidresidue(p.D469del)fromtheseventhT3
repeat (T37), which accounts for approximately 30% of all PSACH
C   2011 WILEY PERIODICALS, INC.[BriggsandChapman,2002;Hechtetal.,1995;Ikegawaetal.,1998].
This archetypal mutation has therefore been extensively studied
both in vivo using patient cartilage and in vitro using cell culture
models; reviewed in Posey et al. [2008]. These studies have con-
sistently shown that p.D469del (and other T3 mutations) result in
the retention of mutant COMP protein within the rER of chondro-
cytes,alongwithmatrilin-3andcollagentypeIX,whileanumberof
chaperoneproteinsareco-localizedwiththeretainedmutantCOMP
[Hecht et al., 2005, 2001]. In addition, cartilage from PSACH pa-
tients has a disorganized ECM and there is an increase in cell death
in vivo [Hecht et al., 2004], which can be recapitulated in vitro
by cell culture models [Duke et al., 2003; Hashimoto et al., 2003].
While cell culture models have recapitulated some of the patho-
logical features in vitro, they are not adequate models to dissect the
disease pathways involved in PSACH. Recently, two mouse models
of D469del COMP have been described that display some of the




to study the disease pathology of PSACH in a more physiologically
relevant model, we report the generation and phenotypic descrip-
tion of the ﬁrst knock-in mouse model generated by homologous
recombination and harboring the common D469del COMP muta-
tion. This model closely recapitulates the human disease pathology
and provides a phenotypically and pathologically relevant model in
which to study the disease pathways that are involved in PSACH.
Here,weprovidetheﬁrstreportofthecellularconsequencesofthe
expressionofD469delCOMPinvivoanddemonstratethatreduced
cell proliferation and increased chondrocyte apoptosis is associated
with a downregulation of peroxiredoxin 2, a gene important for
protecting against oxidative damage and in regulating apoptosis.
Materials and Methods
Generation of Comp D469del Knockin Mice
A 129S6/SvEvTac mouse spleen genomic DNA library was previ-
ously screened for a clone containing the entire Comp gene [Pirog-
Garcia et al., 2007]. A loxP-ﬂanked Neo cassette was cloned into
pBluescript (pBS-Neo) using an EcoRV site in the polylinker se-
quence.ThelongarmoftheconstructwasgeneratedbyEcoRIdiges-
tionandsubcloningofan8-kbgenomicfragmentcontainingComp.
The short arm of the construct (2 kb) was generated by subcloning
ofanEcoRI/SpeIComppositivefragment(6kb).TheCompD469del
change (TGACGATGAT—AATG) was introduced by site-directed
mutagenesis of a 1.6-kb fragment generated by restriction digestion
using a SpeI site in the pBluescript polylinker and a MluI site in the
construct. The primers used for the introduction of the mutation
were; forward (mutation): 5 -T GAC GAT GAT—AAT GAC GGA
G-3 ,r e v e r s e( m u t a t i o n ) :5  - CC C TG T CT T A — A T CA T CG T CA-
3 ,forward:5 -GATGCCTGCGACAACTGCC-5 ,andreverse:5  -
CCTTGTCAGCATCGAAC-3 .Thepresence of themutationwas
conﬁrmed by DNA sequencing. In the short arm of the construct,
anEcoRIrestrictionsitewasmodiﬁedintoaClaIsitebyligationofa
linker oligonucleotide (5 -GAATTATCGATAATTC-3 ). The pBlue-
script vector was modiﬁed by NotI digestion and Klenow blunting,
thus generating a unique FseI site for construct linearization.
R1 (129Sv) embryonic stem (ES) cells were grown on a layer of
G418 (Invitrogen) resistant embryonic feeder cells in a medium
supplemented with leukemia inhibitory factor. The targeting vector
(70 μg) was linearized with FseI and electroporated into 4 × 10 R1
(129Sv) ES cells using a BioRad gene pulser (0.8 kV, 3 μF, 0.1 ms;
Bio-Rad Laboratories Ltd). Electroporated cells were propagated in
selective medium with G418 (500 μg/ml) for 5–6 days and resistant
clones were picked and screened for homologous recombination
by HindIII digestion and Southern blot analysis with an external
1-kb probe. A probe directed against the Neo cassette was used to
conﬁrmsingleincorporationoftheconstructsequenceinthemouse
genome. The presence of the mutation was conﬁrmed by direct
sequencing and the positive clones were grown from frozen stocks
and microinjected into C57BL/6 blastocysts and implanted into
foster mothers. The resulting chimeric animals were assessed on fur
color and mated with a deleter Cre line of transgenic mice to delete
the loxP-ﬂanked selection cassette. Heterozygous F1 offspring were
then mated to generate the animals used in all of the experiments
described. Cre recombination resulted in one loxP site remaining in
theintronicsequence,allowingforgenotypingfromtail-tipgenomic
DNAusingprimersspanningintron16(Extract-N-AmpTMTissue
PCR Kit, Sigma–Aldrich Ltd., Haverhill, UK).
Generation of the COMP D469del Cell Line
Wild-type and mutant (p.D469del) full-length human COMP
cDNA (nucleotides 1–2,271 and including the native signal pep-
tide but missing the stop codon; GenBank accession number
NM_000095.2 with nucleotide 1 counted as the ﬁrst nucleotide
of the translation initiation codon) was cloned in-frame into
the pEGFP-N3 vector (Takara Bio/Clontech, Saint-Germain-en-
LayeFrance) to engineer a green ﬂourescent protein (GTF) tag at
the C-terminus. T25 ﬂasks of 75% conﬂuent HT1080 cells were
transfected with 2 μg of vector DNA using Lipofectin and recombi-
nantcellsselectedusingG418.Followingselectionstablytransfected
cellswereﬂuorescence-activatedcellsorting(FACS)sortedtoenrich
for those cells expressing high levels of the transgene.
Skeletal Preparations and Bone and Growth Rate
Measurements
Individual bone lengths and hip angles were measured from ra-
diographic images taken of 3-, 6-, and 9-week-old mice using pro-
prietysoftware(CertusTechnologyAssociatesLimited,Exeter,UK).
Mice were weighed at 3, 6, and 9 weeks of age and these measure-
ments were used to generate growth curves. All the measurements
were analyzed by one-way ANOVA for statistical signiﬁcance.
Tissue Extraction and Processing for Histology and
Immunohistochemistry (IHC)
Whole femur and tibia knee joints were dissected and ﬁxed for
24 hr in 95% ethanol/5% acetic acid. Tissue samples were then
decalciﬁed for up to 2 weeks in 20% EDTA, pH 7.4. Samples
were processed overnight in a tissue processor (Microm/Thermo
Fisher Scientiﬁc Inc., Walldorf, Germany) and embedded in paraf-
ﬁn wax. Six micrometer Sagittal sections were cut on a microtome
(Microm/Thermo Fisher Scientiﬁc Inc.) and collected on positive
slides (superfrost; VWR International Ltd., Lutterworth, UK). Tis-
sue sections were then used for histochemical and immunohisto-
chemical staining. Slides were dewaxed in xylene, rehydrated in a
graded alcohol series, and H&E stained using an automated stainer
(ThermoShandonLtd., Runcorn,UK)orused forIHCasdescribed
previously [Leighton et al., 2007].




were collected on a FEI Tecnai 12 Biotwin electron microscope
(FEI UK Limited, Cambridge, UK).
Cell Proliferation and Apoptosis Assays
Mice were injected intraperitoneally with BrdU labeling solution
(GEHealthcareLifeSciences,Amersham,UK)andsacriﬁcedafter2
hr.Kneejointsweredissectedandprocessedaspreviouslydescribed
[Pirog-Garcia et al., 2007]. IHC was performed using an anti-BrdU
antibody (1:100; Abcam, Cambridge, UK) with a biotinylated sec-
ondary rabbit anti-rat IgG, (1:200; Dako cytomation, Cambridge,
UK). Images of the growth plate were collected using an Axiovision
microscope software (Carl Zeiss Ltd., Welwyn Garden City, UK)
and the proportion of BrdU positive cells (brown stain) compared
tothetotalnumberofcells(Dapistain)intheproliferativezonewas
determined for each genotype. The results were quantiﬁed using
one-way ANOVA.
Apoptosis was visualized using the DeadEnd TM ﬂuorometric
TUNEL assay (Promega UK, Southampton, UK) with citrate buffer
used for unmasking [Pirog-Garcia et al., 2007]. Images were col-
lected using an Axiovision microscope software (Carl Zeiss) and
statistic analysis performed by independent sample t-test.
Real Time qRT-PCR
Cartilage was dissected from 5-day-old mice (rib) or 3-week-
old mice (xiphoid) of pooled mixed gender litters and snap frozen
in liquid nitrogen. The tissue samples were then homogenized in
TRIzol (Invitrogen, UK) using a micro-dismembranator (2,000
rpm for 2 min) and the RNA was isolated as per the man-
ufacturer’s protocol. RNA concentration was determined by a
Nanodrop ultra-low-volume spectrophotometer. RNA samples of
0.5 μg were subsequently used to synthesize ﬁrst strand cDNA
using superscript III (Invitrogen) and real-time analysis of wild-
type and mutant mRNA levels was performed using a SYBR
R  
Green Kit on a ABIPrismTM 7000 sequence detector system
(Applied Biosystems, Warrington, UK) as described previously
[Leighton et al., 2007; Nundlall et al., 2010; Pirog-Garcia et al.,
2007]. Primer sequences were: Grp78/BiP: 5 -GGCACCTTCG-
ATGTGTCTCTTC-3  and rev: 5 -TCCATGACCCGCTGATCAA-
3 ; Grp94: 5 -TAAGCTGTATGTACGCCGCGT-3  and rev: 5 -
GGAGATCATCGGAATCCACAAC-3 ;Cnx:5  -TGATTTCCTCTC
CCT CCC CTT-3  and rev: 5 -CAC TGG AAC CTG TTG ATG GTG
A-3 ;C r t :5  -GCT ACG TGA AGC TGT TTC CGA-3  and rev: 5 -
ACATGAACCTTCTTGGTGCCAG-3 ;Erp72:5 -AGTATGAGC
CCA GGT TCC ACG T-3  and rev: 5 -AGA AGT CTT ACG ATG
GCC CAC C-3 . Each experiment included “no template” controls,
wasruninduplicate,andhadan18SRNAcontrol.Eachexperiment
was repeated three times for statistical relevance and the results an-
alyzed by independent samples t-test.
SDS-PAGE and Western Blotting
Rib cartilage from 5-day-old mice or xiphoid cartilage from 3-
week-old mice was homogenized in 100 μld H 2Op e r5m gt i s s u e ,
boiled in SDS loading buffer containing dithiothreito (DTT) and
40 μl of total protein was loaded on an SDS-PAGE gel. The gel was
electroblotted onto a nitrocellulose membrane, which was blocked
overnight with 2% skimmed milk powder in phosphate buffered
saline-triton (PBS-T). The COMP antibody (GeneTex Inc/Patricell
Ltd., Nottingham, UK) was used at a dilution of 1:100 and antibod-
ies to chaperones associated with the UPR were used at a dilution
of 1:500 (Grp78, Grp94, Erp72; all from Santa Cruz Biotechnol-
ogy, Inc., Santa Cruz, CA, USA). The Western blots were scanned
and analyzed by densitometry using the AIDA32 software and then
normalized to Ponceau staining for total protein (n ≥ 3 litters per
genotype [∼5–8 mice per litter of mixed gender] and ≥3 separate
experiments were performed in duplicate).
Adherent HT1080 cells transfected with GFP vector alone, GFP-
COMPwild-typeorGFP-COMPmutantwereculturedinT75ﬂasks
in DMEM4 (Sigma-Aldrich Ltd., Haverhill, UK) supplemented
with 10% FBS (Fisher Scientiﬁc UK Ltd., Loughborough, UK),
1% Penicillin/Streptomycin 100× solution (Sigma-Aldrich), 1% of
200 mM L-Glutamine solution (Sigma-Aldrich), 1% nonessential
amino acids 100× solution (Sigma-Aldrich), and 360 mg/L G418,
changing medium every second day. After they reached conﬂuence,
cells were cultured in the same medium for 48 or 72 hr, washed
three times in ice-cold PBS and lysed in 1 ml of RIPA buffer (150
mM NaCl, 1% Na Deoxycholate, 0.1% SDS, and 10 mM Tris-HCl,
pH 7.4) on ice for 15 min. Cell lysates were centrifuged at 13,000 g
for 10 min at 4◦C and the supernatants were collected. An aliquot
of the supernatant was used for protein concentration evaluation.
Cell lysates were then boiled for 5 min in SDS-PAGE loading buffer
containing DTT. Twenty micrograms of proteins were loaded on
an SDS-PAGE 4–12% precast gel (Invitrogen) and electroblotted
on a nitrocellulose membrane, which was blocked overnight with
2% skimmed milk powder in PBS-T. The monoclonal COMP anti-
body (clone 12C4) was used at a dilution of 1:1000; the Polyclonal
PRDX2 antibody (ProteinTech Europe, Manchester, UK) and the
monoclonal β actin antibody (Abcam, Cambridge, UK) were used
at a dilution of 1:500.
Microarray Hybridization and Statistical Analysis
For the microarray analysis, RNA was isolated using TRIzol (In-
vitrogen,UK)fromtheribchondrocytesofnewbornand5-day-old
mice[Nundlalletal.,2010],andthecellculturemodelat48hrafter
conﬂuence. In order to analyze gene expression in mice that were
homozygous for Comp D469del, hybridizations were performed on
threeseparateRNAsamples(3×mutantand3×wild-type)isolated
from chondrocytes pooled from ﬁve littermates of mixed gender.
Only one RNA sample (one × mutant litter and one × wild-type
litter of mixed gender) was examined from mice heterozygous for
Comp D469del or homozygous for Matn3 V194D [Nundlall et al.,
2010].
RNA quality was assessed using the RNA 6000 Nano Assay and
analyzed on an Agilent 2100 Bioanalyser (Agilent Technologies UK
Ltd., Edinburgh, UK). RNA concentration was quantiﬁed using a
Nanodrop ultra-low-volume spectrophotometer (Nanodrop Tech-
nologies, Wilmington, DE, USA). The hybridization cocktail was
hybridized to either the Mouse 430_2 oligonucleotide array or Hu-
man HG-U133_plus_2 array (Affymetrix UK Ltd., High Wycombe,
UK)according tothemanufacturers’instructions.Arrayswere read
using an Agilent GeneArray scanner 3000 7G and processed us-
ing Affymetrix GCOS (V1.4) software. Statistical analysis was per-
formed using Robust Multi-array Average (RMA), which is an al-
gorithm used to generate expression proﬁles from Affymetrix data
[Irizarry et al., 2003].
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Generation of the Comp D469del Knockin Mouse Line
Mice harboring the Comp D469del mutation in the TSP3 region
of COMP were generated by homologous recombination in R1 ES
cells using an appropriate targeting strategy (Supp. Fig. S1). The
“long arm” of the targeting construct (8 kb) contained exons 1–16
of Comp and the “short arm” of the construct (2 kb) contained
exons 17–19 of Comp (Supp. Fig. S1A). The 3-bp deletion required
to produce the D469del mutation was introduced into exon 13 of
Comp bysite-directedmutagenesis.ThreehundredandsixtyEScell
clonesthathadbeenelectroporatedwiththetargetingconstructand
selected by antibiotic resistance were analyzed for homologous re-
combinationusingSouthernblottingwithanexternalprobe(Supp.
Fig. S1B). The presence of the mutation was conﬁrmed by direct
sequencingofDNAfromESclonesthathadsuccessfullyundergone
homologous recombination. Positive clones resulting from the tar-
geting procedure were microinjected into C57BL/6 blastocysts and
then implanted into pseudopregnant foster mothers. The resultant
chimeric mice were used for the foundation of a transgenic line and
a breeding strategy was used to obtain wild-type mice and mice
thatwereeitherheterozygousorhomozygousforthemutation.The
presence of the mutation was again conﬁrmed in mice that were
homozygous for D469del (Supp. Fig. S1C).
COMP mRNA and Protein Expression Levels are
Comparable between Wild-Type and Mutant Mice
Cartilagefrom3-week-oldmicewasusedforRNAextractionand
forSDS-PAGE,andWesternblotanalysisoftotalproteintoconﬁrm
that the D469del mutation did not affect the expression of either
Comp alleles. Prior to qRT-PCR, ﬁrst strand cDNA was analyzed
to ensure that there was no contamination from genomic DNA.
This was achieved by performing PCR using a primer pair span-
ning intron 15 of the COMP gene, which conﬁrmed that there was
no contamination from genomic DNA (Supp. Fig. S1D). There-
after, qRT-PCR using Comp-speciﬁc primers was performed and
this analysis conﬁrmed comparable Comp mRNA levels in chon-
drocytesfromwild-typeandmutantmice(0.92 ±0.09;wtvs.mut).
Total COMP protein levels in cartilage were determined by SDS-
PAGE analysis of DTT-reduced total protein samples followed by
Western blotting using a COMP-speciﬁc antibody. Protein bands
corresponding to wild-type and mutant COMP were present at ap-
proximately 100 kDa, which corresponded to the COMP monomer
(Supp. Fig. S1E). Wild-type and mutant cartilage protein samples
showed comparable levels of COMP when normalized to Ponceau
stainingandquantiﬁedbydensitometry(datanotshown).Further-
more, protein samples run under non-reducing conditions demon-
stratedthatmutantCOMPformedthecorrectpentamericstructure
(data not shown).
Mutant Mice are Normal at Birth but Develop a Progressive
Short-Limb Dwarﬁsm and Hip Dysplasia
AnormalMendeliandistributionof1:2:1(wt/wt:m/wt:m/m)was
observed in litters produced from crosses of mice heterozygous for
the Comp D469del mutation. There were no overt skeletal defects
observed at birth in mice of any genotype (data not shown), an
observation that is consistent with human PSACH patients when
the clinical presentation only becomes apparent in early childhood.






(P < 0.05) less that their wild-type and heterozygous littermates. By
9weeks of age, thedifferences in weight were statisticallysigniﬁcant
forbothmaleandfemalemicehomozygousforthemutation(males
∼10%, P < 0.02 and females ∼8%, P < 0.05).
Radiographs of individual mice of all three genotypes were col-
lected at 3, 6, and 9 weeks of age and bone length measurements
were performed (Fig. 1 and Supp. Fig. S3). To determine the effect
ofthemutationonintramembraneousossiﬁcation,skulllengthand
inner canthal distance (ICD) were measured; while the lengths of
the pelvis, femur, and tibia were used to determine the effect of the
mutation on endochondral ossiﬁcation. At 9 weeks of age, the mice
homozygousforthemutationappearedshorterthantheirwild-type
littermates and the ﬁnal reduction in adult male bone lengths, rel-
ative to wild-type controls, was 6% (P < 0.05) for the femur, 7%
(P < 0.05) for the pelvis, and 5% (P < 0.05) for the tibia (Fig. 1B). In
female mice, the ﬁnal reduction in adult bone lengths was 6% (P <
0.05) for the femur, 3% (P < 0.001) for the pelvis, and 6% (P < 0.05)
forthetibia(datanotshown).Incontrast,therewerenodifferences
in either the skull length or ICD for mice of all three genotypes and
at all time points analyzed (Fig. 1B and data not shown).
Patients with PSACH develop a waddling gait during childhood
and we were interested to determine if Comp D469del mutant mice
developed a hip dysplasia similar to that reported for Comp T585M
mutant mice [Pirog-Garcia et al., 2007]. In order to determine the
effect of the mutation on the development of the pelvis, the angle
of deﬂection from the vertical of the tuberosity of the ischium was
measured at 3, 6, and 9 weeks of age in mice of all three genotypes
(Fig. 1C; only 9 weeks is shown). Interestingly, at 9 weeks of age the
angle at the hip was greater in mice homozygous for the mutation
when compared to their wild-type or heterozygous littermates. In
males, the angle of deﬂection was increased by >57% (P < 0.01)
(Fig. 1D; 10◦ in wild-type mice compared to 16◦ in mice homozy-
gous for the mutation). In female mice, there was a >48% (P < 0.05)
increase in the angle of deﬂection from 10.4◦ in wild-type mice to
15.4◦ in mice homozygous for the mutation (data not shown).
Mutant Mice Exhibit Abnormal Growth Plate Morphology
Characterized by Disorganized Chondrocyte Columns and
Areas of Hypocellularity in the Proliferative Zone
By 3 weeks of age, the growth plates of wild-type mice were
well organized with ordered columns of proliferating chondro-
cytes, while a distinct hypertrophic zone was visible that was ter-
minated by a regular vascular invasion front (Fig. 2A). In con-
trast, mice homozygous for the mutation had an abnormal growth
plate characterized by disorganized chondrocytes within individual
chondrons, while the chondrons themselves were also misaligned
within each column and in some cases individual chondrocytes
wereseentobealignedatrightanglestotheirusualhorizontalplane
(Fig.2B;redcircles).Moststrikinghoweverweretheobviousareasof
hypocellularity in the resting and upper proliferative zones of the
mutant growth plates (Fig. 2B; asterisks). Furthermore, there ap-
peared to be no clear distinction between the proliferative and hy-
pertrophiczonesofthegrowthplateandthevascularinvasionfront
was also irregular. The growth plates of mice heterozygous for the
mutation were comparable to those of wild-type mice in that they
had an organized growth plate with clear proliferative and hyper-
trophic zones and a regular vascular invasion front, however, some
HUMAN MUTATION, Vol. 33, No. 1, 218–231, 2012 221Figure 1. Mutant COMP mice are normal at birth but develop short-limb dwarﬁsm by 9 weeks of age. A: Individual mice were radiographed at
3, 6, and 9 weeks of age; radiographs of 9-week-old mice are shown. B: Bone measurements of male littermates at 9 weeks of age with inner
canthaldistance(ICD)usedasamarkerofintramembranousossiﬁcation,andthefemur,tibia,andpelvislengthsusedasmarkersofendochondral
ossiﬁcation. The differences in femur, tibia, and pelvis lengths between wild-type males and males homozygous for the mutation were >6%, >5%,
and >7%, respectively (n ≥ 7 mice per genotype; One-way ANOVA, ∗P < 0.05). C: The angle (◦) between the tuberosity of the ischium and the pelvic
region was measured at 3, 6, and 9 weeks of age in mice of all three genotypes. D: The hip angle was >57% greater for males homozygous for the
mutation compared to their wild-type littermates at 9 weeks (n ≥ 7 mice per genotype; One-way ANOVA, ∗∗P < 0.005). wt, wild-type; wt/m, mice
heterozygous for the mutation; m/m, mice homozygous for the mutation.
regions of hypocellularity were observed within the proliferative
zone indicating an intermediate phenotype (data not shown).
Mutant COMP is Retained within Growth Plate
Chondrocytes Along with Matrilin-3 and to a Lesser Extent
Type IX Collagen
I H Cw a sp e r f o r m e do nt h et i b i ag r o w t hp l a t e so f3 - w e e k - o l d
mice to determine the localization of key structural components,
in particular COMP, matrilin-3 and type IX collagen, which are
knowntointeractwitheach other.Extracellular stainingforCOMP
was observed in the growth plates of wild-type mice (Fig. 2C) and
mice heterozygous for Comp D469del (not shown). However, ex-
tracellular staining of COMP was markedly reduced in the growth
plates of mice homozygous for the mutation, in particular within
the proliferative zone, where chondrocytes were also seen to have
lost the “white” appearance of their pericellular matrix (Fig. 2D; ar-
rows). In contrast, chondrocytes within the resting zone of mutant
growth plates appeared to have more intense staining for COMP
in the pericellular matrix compared to wild-type (Fig. 2C and D;
red squares). Most notable, however, was the intracellular staining
for mutant COMP, which was most pronounced in chondrocytes
within the hypertrophic zone (Fig. 2D; insert), although a few pro-
liferative chondrocytes also had retained mutant COMP (Fig. 2D;
blue circles).
Extracellular staining for matrilin-3, which was comparable to
COMP staining, was observed in wild-type mice and in mice het-
erozygous for the mutation (Fig. 2E, not shown). Although ECM
staining for matrilin-3 was present in the growth plates of mice
homozygous for the Comp D469del mutation, there was also some
intracellular staining seen in the hypertrophic chondrocytes, al-
though this staining was less intense than that seen for mutant
COMP (Fig. 2E; insert). Interestingly, there was a similar concen-
trationofmatrilin-3staininginthepericellularmatrixsurrounding
222 HUMAN MUTATION, Vol. 33, No. 1, 218–231, 2012Figure 2. The organization of the growth plate in mutant mice is disrupted by 3 weeks of age and shows marked hypocellularity along with the
mislocalization of cartilage structural proteins. Representative images from the growth plates of 3-week-old wild-type and mutant mice. A and B:
H&E staining showed disruption to the growth plate by 3 weeks of age in mice homozygous for the Comp D469del mutation. This disruption was
characterized by fewer and more disorganized columns of chondrocytes in the proliferating zone, with distinct areas of hypocellularity (∗) and
individual chondrocytes that were at right angles to their usual horizontal plane (red circles). IHC using COMP (C and D), and matrilin-3 (E and
F) antibodies revealed less staining in the ECM between the proliferating columns in the growth plates of mice carrying the D469del mutation.
Furthermore, there was intracellular staining for mutant COMP and matrilin-3 in chondrocytes from mice homozygous for D469del (insert) and
chondrocytes in the mutant growth plates had lost the “clear” appearance of their pericellular matrix (black arrows). Extracellular staining for
COMP and matrilin-3 in the resting zone of the mutant growth plates was restricted to the pericellular matrix surrounding chondrocytes (D and F;
red boxes) compared to the wild-type growth plates (C and E; red boxes). mut/mut, mice homozygous for D469del.
chondrocytesintherestingzoneofthemutantgrowthplatethatwe
had observed with mutant COMP (Fig. 2E and F; red boxes).
Finally,asmallamountofintracellularstainingwasalsoobserved
for type IX collagen in chondrocytes from the growth plates of
mice homozygous for the mutation when compared to those of
heterozygous mice and wild-type controls (Supp. Fig. S4A and B).
Furthermore, in mice of all three genotypes staining for type IX
collagen was more pronounced in the resting and early proliferative
zones, but there were no differences in the localization of type IX
collagen in the ECM of mutant mice as seen with both COMP and
matrilin-3.
The Growth Plates of Mutant Mice Also Have
Mislocalization of Type II and Type X Collagen
Type II and type X collagen are essential for correct skeletal de-
velopment and are important cartilage markers; in particular type
Xcollagen,whichisexpressedexclusivelybyhypertrophicchondro-
cytes [Morrison et al., 1996]. Wild-type and mutant growth plates
showed no overt differences in the extracellular staining for type II
collagen (Supp. Fig. S4C and D) and as expected type X collagen
stainingwasobservedonlyintheECMofthehypertrophiczonefor
miceofallthreegenotypes,however,staininginthegrowthplatesof
HUMAN MUTATION, Vol. 33, No. 1, 218–231, 2012 223Figure3. ChondrocyteshavedilatedcisternaeofERandtheECMultrastructureisalteredinmutantgrowthplates.AandB:Theserepresentative
imagesweretakenfromacompleteTEMmontageofaday7tibiagrowthplate(fromrestingtomineralizationzones)andshowfourcellchondrons
from the proliferative zone. Chondrocytes from mutant mice show enlarged individual cisternae of ER (D) compared to the wild-type mice in which
the ER has a typical ribbon appearance (C). E and F: The ultrastructure of the interterritorial matrix at 1 week of age is altered in mut/mut growth
plates and is characterized by more prominent appearing collagen ﬁbrillar material. Scale bars are 3.0 μm( A), 2.3 μm( B), or 1.2 μm( E and F).
mut/mut, mice homozygous for D469del.
mice homozygous for the mutation was uneven and appeared dif-
fuse,particularlyattheproliferative–hypertrophicboundary(Supp.
Fig. S4E and F).
Ultrastructural Analysis Conﬁrms An Enlarged rER in
Mutant Chondrocytes and Abnormal Changes to ECM
Morphology in Mutant Cartilage
The tibia growth plates from 7-day-old mice were studied by
transmission electron microscopy (TEM) to observe individual
chondrocytes and their associated ECM (Fig. 3). While the ER of
wild-typechondrocytesappearedwithinnormallimits(Fig.3Aand
C), most chondrocytes in the growth plates of mice homozygous
for the Comp D469del mutation showed enlarged cisternae of ER
that was consistent with the retention of mutant COMP and other
proteins (Fig. 3B and D). Hypertrophic chondrocytes from wild-
type mice were rectangular in shape and the condensation of chro-
matin was clearly visible. In contrast, hypertrophic chondrocytes
frommicehomozygousforthemutationweregenerallyirregularin
shape and showed the persistence of protein within remnants of the
ER (data not shown). In addition, there were clear changes in the
morphology of the ECM in the pericellular region of the cartilage
growth plate (Fig. 3E and F). This included more pronounced ap-
pearing collagen ﬁbrils, which is consistent with a reduction in the
224 HUMAN MUTATION, Vol. 33, No. 1, 218–231, 2012Figure 4. Cell proliferation is decreased and apoptosis is both increased and spatially dysregulated in 3-week-old tibias of mutant mice. A:
Chondrocyte proliferation, assayed by 2 hr BrdU labeling, was signiﬁcantly reduced in growth plates of mice homozygous for the D469del mutation
(by∼17%;n=36sectionsfromthreemicepergenotype,independentsamplest-test, ∗∗P<0.005).B:TUNELpositive(apoptotic)cells(whitecircles)
were detected in the proliferative and hypertrophic zones of growth plates from mice homozygous for the D469del COMP mutation, but not in
their wild-type littermates. The white lines mark the boundaries between the vascular invasion front, hypertrophic, and proliferative zones in the
growth plate, and DAPI staining was used as a nuclear counterstain. C: Quantiﬁcation of the TUNEL assay results showed a signiﬁcant increase
in apoptosis in the hypertrophic (>ﬁvefold) zone of growth plates from mice homozygous for the mutation (n = 36 sections from three mice per
genotype, independent samples t-test, ∗∗∗P < 0.001). wt, wild-type; mut/mut, homozygous for D469del; VIF, vascular invasion front.
levels of ﬁbril surface-associated material (such as COMP) as seen
in the other mouse models of PSACH-MED [Leighton et al., 2007;
Pirog-Garcia et al., 2007].
Chondrocyte Proliferation Is Decreased in Mutant Mice
While Apoptosis Is Increased and Spatially Dysregulated
Thespatialandtemporalregulationofchondrocyteproliferation
and differentiation within the growth plate is crucial for correct
bonegrowth.Therefore,tohelpidentifyamechanisticlinkbetween
the expression of Comp D469del and reduced longitudinal bone
growth, we studied the relative rates of chondrocyte proliferation
and apoptosis in the growth plate.
To determine the effect of mutant Comp expression on chon-
drocyte proliferation, we used 2 hr BrdU labeling experiments on
3-week-old mice. Within the proliferative zone of the growth plates
of wild-type mice 18% (±1.84%) of cells were labeled with BrdU,
while only 14.8% (±1.95%) of cells were labeled in the growth
plates of mice homozygous for Comp D469del, which corresponds
to a decrease of 17% (P < 0.05) in the relative rates of chondrocyte
proliferation in mutant growth plates (Fig. 4A). The relative levels
of cell proliferation within growth plates of mice heterozygous for
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not shown).
To determine the cytotoxic effect of mutant Comp expression
on chondrocyte viability, we performed the TUNEL assay on tibia
growth plate sections from 3-week-old mice. In wild-type animals,
TUNEL positive chondrocytes were observed primarily at the vas-
cular invasion front and typically 1–2 positive cells were counted
per section, whereas there were very few TUNEL positive cells in
t h eh y p e r t r o p h i cz o n ea n dn o n ea ta l lo b s e r v e di nt h ep r o l i f e r -
ative zone of the growth plate (Fig. 4B; left panel). In contrast,
there was a > ﬁvefold increase (P < 0.0001) in TUNEL positive
cells in the hypertrophic zone of mice homozygous for the muta-
tion (Fig. 4C) and we also observed numerous clusters of TUNEL
positive chondrocytes in the proliferative zone (Fig. 4B; right
panel).
In order to identify the initial time of onset and subsequent pro-
gression of chondrocyte apoptosis, we also performed the TUNEL
assay on the tibia growth plates of 5-day-old and 2-week-old mice
that were wild-type and homozygous for Comp D469del (Supp.
Fig. S5A). There was a ∼threefold increase in apoptosis in the pro-
liferativezoneof5-day-oldmiceanda∼ﬁvefoldincreasein2-week-
old mice compared to wild-type littermates (Supp. Fig. S5B). There
was no increase in apoptosis in the hypertrophic zone of 5-day-
old mice, but a ∼twofold increase in 2-week-old mice compared to
wild-type littermates (data not shown). Overall these data conﬁrm




The Expression of Comp D469del Does Not Induce a
Conventional Unfolded Protein Response (UPR)
Studies on COMP mutations to date have shown that mutant
COMPisco-localizedwithchaperoneproteinsintheERofchondro-
cytes from PSACH patients [Hecht et al., 2001; Vranka et al., 2001].
Furthermore, we have recently reported a UPR in mouse models of
PSACH-MED harboring mutations in Comp (T585M) and Matn3
(V194D) [Boot-Handford and Briggs, 2009; Leighton et al., 2007;
Nundlall et al., 2010; Pirog-Garcia et al., 2007]. Therefore, in order
to determine if the expression of Comp D469del caused a UPR, we
looked at the relative expression of key chaperone proteins using
a combination of real time PCR and SDS-PAGE Western blotting.
qRT-PCR analysis showed no relative increase in the expression of
Grp94andGrp78/BiPat5daysofageandGrp94,Grp78/BiP,Erp72,
Cnx,andCrtat3weeksofage(Table1).Thecorrespondingprotein
levels of these chaperones was determined by Western blotting of
intracellular proteins, which conﬁrmed that there was no increase
in the relative intracellular levels of Grp94, Grp78/BiP, and Erp72
in mutant chondrocytes at 3 weeks of age (Table 1). Furthermore,
we could not detect any increase in the levels of phosphorylated
eIF2α, a key downstream mediator of the UPR and there was also
no increase in the relative expression of Chop a t5d a y sa n d3w e e k s
o fa g e( T a b l e1 ) .
W ea l s op e r f o r m e dm i c r o a r r a ya n a l y s i so nR N Ai s o l a t e df r o m
the rib chondrocytes of newborn and 5-day-old mice that were
eitherheterozygous(5day)orhomozygousnewborn(newbornand
5d a y )f o rComp D469Del relative to the wild-type controls. These
data conﬁrmed that there was no increase in the relative expression
of more than 250 genes associated with a conventional UPR (Supp.
Table S1 and S2), some of which have previously been shown to
be upregulated in chondrocytes from mice harboring the Matn3
Table 1. The Expression Levels of Selected ER Stress and
UPR-Associated Genes was Determined Using qRT-PCR Analysis
of mRNA Isolated from Chondrocytes at 5 Days and 3 Weeks of
Age and Western Blotting of Total Cartilage Protein Isolated from
the Cartilage of 3-Week-Old Mice
mRNA Protein
ER stress/UPR marker
5D a y s
(wt vs. mut)
3W e e k
(wt vs. mut)
3W e e k
(wt vs. mut)
Grp94 0.57 (±0.17) 1.21 (± 0.32) 1.27 (±0.19)
Grp78/BiP 0.93 (±0.28) 1.20 (±0.18) 1.04 (±0.12)
Erp72/Pdia4 - 1.11 (±0.31) 1.31 (±0.18)
Calnexin - 0.71 (±0.23) -
Calreticulin - 0.76 (±0.27) -
CHOP 0.71 (±0.03) 0.91 (±0.35)
eIF2α - - 1.06 (±0.31)
eIF2αP - - 0.98 (±0.09)
The table shows the relative levels of mRNA or protein in mutant samples compared
to wild-type controls (wt vs. mut ± SEM). n ≥ 3l i t t e r sp e rg e n o t y p e( ∼5–8 mice per
litter) and ≥3 separate experiments were performed in duplicate.
V194D mutation [Nundlall et al., 2010]. The only exception was
ﬁbroblastgrowthfactor18(Fgfr18),whichwasupregulatedtwofold
in newborn homozygous mutant mice. Finally, human HT1080
ﬁbrosarcomacellsexpressingtheCOMPp.D469delmutation,which
showed the retention of mutant COMP protein (Supp. Fig. S6)
also failed to demonstrate a conventional UPR (Supp. Table S2),
thereby conﬁrming consistency between relevant in vivo and in
vitro models.
Gene Expression Studies Show a Complex Disease Proﬁle
Implicating Oxidative Stress, Apoptosis, and Cell Cycle
Arrest in the Pathogenesis of PSACH
Following the unequivocal exclusion of a classical UPR as a po-
tential disease mechanism in Comp D469del mice, the Robust Mul-
tiarray Averaging (RMA) method was used to ascertain the top
20 signiﬁcantly up- and downregulated genes in the chondrocytes
from newborn and 5-day-old mice in order to identify potential
genetic pathways involved in the pathogenesis of PSACH (Supp.
Table S3–S6).
The genes upregulated in chondrocytes from newborn mice
were clustered into the following groupings; oxidative stress (Abcc9,
Rgs5, Cdh5), cell proliferation and/or apoptosis (Igfbp3, Kera, Cilp,
Lamb1-1, Sdpr, Sox17), cell attachment and/or migration (Ibsp,
Chodl, Cd93, Cd34, Thbs4, Cdh5, Egﬂ6), cell survival (Ednrb), and
NF-κB signalling (Meox2) (Supp. Table S3). The most highly up-
regulated gene was Igfbp3 (↑12.19), which has been shown to in-
duce rapid apoptosis in a non-IGF-dependant manner and has an-
tiproliferative effects via the transforming growth factor β (TGF-β)
signalling pathway [Han et al., 2011; Lee et al., 2005]. The down-
regulated genes included those linked with NF-κB signalling (Ccl5,
Prdx2, T2bp, Hivep3, Tac1, Srxn1), cell proliferation (Pfkfb3), cell
survival (Bdkrb1), cell signalling (Gng4, Lif, Otos, A2m, Rspo3), and
cell cycling (Rnd1) (Supp. Table S4). Interestingly, we found the
downregulation of three members of the chemokine ligand protein
family, namely Ccl5, Cxcl2, and Cxcl16, and also other genes that
were involved in the same pathways such as Hivep3 and T2bp.
By 5 days of age, the upregulated genes included those in-
volvedinoxidativestressanddegradativepathways(Amacr,Hmox1,
Car3, Arsj, Ctsc, Heph), cell survival and/or proliferation (Iﬁ202b,
Camk4, Sox11, Snca, Agtr2), regulators of insulin receptor and
IGFBP-3-dependent effects (Enpp1, Lyve1), and NF-κB signalling
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included those implicated in oxidative stress (Npas4, Prdx2), apop-
tosis (Camk2d, Adi1), cell cycle control (Ddx3y, Eif2s3y), cell pro-
liferation/migration and cell–cell interactions (Lypd3, Gjb4, Bop1,
Cdh1, Hbegf, Trio), and NF-κB signalling pathways (Prdx2, Snno2)
(Supp. Table S6).
The Downregulation of Peroxiredoxin-2 is a Consistent
Finding in Both Mutant Mice and the Cell Culture Model
Interestingly, the only gene whose expression was consistently
changedatbothtimepointswasPrdx2,whichwasdownregulatedat
bothnewborn(↓3.89)and5daysofage(↓2.91)(Supp.TableS4and
S6). Furthermore, PRDX2 expression was also signiﬁcantly down-
regulated in the HT1080 cell culture model of COMP p.D469del
(↓2.60)andat5daysinmiceheterozygousforthemutation(↓3.32)
(data not shown). In view of these data and given the known as-
sociation between the downregulation of PRDX2 and apoptosis in
human diseases such as Down syndrome and Fuchs Endothelial
Dystrophy (FED) [Jurkunas et al., 2008; Sanchez-Font et al., 2003],
we used a combination of Western blotting and IHC to validate
the downregulation of peroxiredoxin-2 both in vivo and in vitro.
Total protein was extracted from the cartilage of 3-week-old mice
and used for SDS-PAGE and Western blotting (Fig. 5A). Following
normalization by Ponceau staining for total protein, densitometry
conﬁrmed that the protein levels of peroxiredoxin-2 were signiﬁ-
cantlyreducedby13%(P <0.0003)inmutantchondrocytesrelative
to wild-type (Fig. 5B). In addition, total cell lysate samples were
collectedfromHT1080cellsat48and72hrafterconﬂuenceandthe
relative levels of peroxiredoxin-2 were quantiﬁed by densitometry
after normalizing to a β actin loading control (Fig. 5C). There was
a >95% (P < 0.0001) decrease in the levels of peroxiredoxin-2 in the
COMPp.D469delmutantcelllinecomparedtowild-type(Fig.5D).
Finally, IHC was performed on the tibia growth plates of 3-week-
old mice homozygous for the Comp D469del mutation and their
wild-type littermates. This analysis demonstrated the intracellular
stainingofperoxiredoxin-2ingrowthplatechondrocytesfrommu-
tant mice was much reduced in chondrocytes from wild-type mice
growth plates (Fig. 5E).
Discussion
A single mutation in COMP, the in-frame deletion of an aspartic
acid codon (p.D469del) from the T37 calcium-binding repeat of
COMP, is responsible for approximately 30% of all PSACH [Hecht




relevant mouse model of PSACH to closely model the phenotypic
andcellularconsequencesofCompD469del.However,incontrastto
the human PSACH phenotype, which is a dominant disease, both
copies of the Comp D469del allele were required for the mice to
develop a quantiﬁable chondrodysplasia phenotype. We have pre-
viously noted similar differences in other mice models of PSACH
a n dM E D ,s u c ha sComp Thr585Met [Pirog-Garcia et al., 2007] and
Matn3 Val194Asp [Leighton et al., 2007], and metaphyseal chon-
drodysplasia type Schmid Col10a1 Asn617Lys [Rajpar et al., 2009].
Furthermore, a mouse model of achondroplasia showed a similar
inconsistency[Lietal.,1999]andthesediscrepanciesinphenotypic
presentation are suggestive of dominance modiﬁcation [Dixon and
Dixon, 2004; Nadeau, 2001]
Mutant mice were normal at birth but developed signiﬁcant
short-limbdwarﬁsmby9weeksofage(Fig.1).Thisisconsistentwith
the clinical progression of the PSACH phenotype in which patients
are normal at birth but during childhood they exhibit progres-
sive short-limbed dwarﬁsm [Maroteaux and Lamy, 1959; Rimoin
et al., 1994]. Mutant mice also developed a progressive hip dyspla-
sia, which was characterized radiographically by a deﬂection from
theverticalofthetuberosityoftheischium(Fig.1).Thisobservation
was consistent with, although more severe than that reported in the
Comp T585M [Pirog-Garcia et al., 2007], Col10a1 N617K [Rajpar
et al., 2009] and Dtdst A386V [Forlino et al., 2005] mutant mice.
In contrast, neither a transgenic Comp D469Del mouse [Schmitz
et al., 2008] nor the Matn3 V194D mice [Leighton et al., 2007] had
arecognizablehipdysplasia,eventhoughtheformerdisplayedster-
nal malformations. This disparity in radiographic presentation in
the transgenic Comp D469Del mouse may be due to differences in
the level of transgene expression, while the Matn3 V194D mutation
may not have as pronounced an effect on the development of the
pelvis.
The chondrocyte columns in the growth plates of mutant mice
were disorganized and there were distinct changes to the morphol-
ogyofindividualchondrocytes.Immunohistochemicalanalysisalso
showed the retention of COMP, matrilin-3, and to a lesser extent
type collagen IX, within the chondrocytes of mutant mice (Fig. 2).
Numerous studies to date, both in vitro and in vivo, have con-
sistently shown the accumulation of mutant COMP and since it
interacts with both matrilin-3 and type IX collagen in vitro these
interactions are possibly the cause of their co-retention. The effect
that the retained mutant COMP has on the trafﬁcking of type II
collagenhasnotbeenfullyresolvedandthereareconﬂictingreports
as to whether type II collagen and other cartilage ECM molecules
(such as aggrecan) are also retained in the rER of chondrocytes
[Hecht et al., 2001; Vranka et al., 2001]. Our own IHC studies sug-
gest that type II collagen is not co-retained with mutant COMP in
the rER, however, there were clear differences in the localization of
type II collagen in the ECM, which may be a direct consequence of
the defect in trafﬁcking of COMP, matrilin-3, and type IX collagen
and/or the reduced levels of these proteins in the cartilage ECM
(Supp. Fig. S4). Alternatively, the presence of mutant COMP in the
ECM may disrupt speciﬁc interactions, thereby inﬂuencing in turn
thelocalizationofitsbindingpartners.Thishypothesisisconsistent
with the pericellular localization of mutant COMP and wild-type
matrilin-3 in the resting zone of mutant growth plates (Fig. 2D
and F).
Quite striking were the regions of hypocellularity within the pro-
liferative zone (Fig. 2), which were consistent with the signiﬁcantly
increasedanddysregulatedapoptosiswithinthiszoneofthegrowth
plate. This ﬁnding is in agreement with studies on cultured PSACH
chondrocytes, which show an increase in cell death following pro-
longed culture in vitro [Duke et al., 2003], and also a transgenic
model of Comp D469del in which there was a signiﬁcant increase
in cell death when it was crossed onto a Comp null background
[Schmitz et al., 2008]. However, in this transgenic model the in-
crease in apoptotic cells was primarily detected at the interface with
thesecondarycenterofossiﬁcation,whichisindirectcontrasttoour
knock-inmodelinwhichincreasedapoptosisisseenintheprolifer-
ative and hypertrophic zones. It is difﬁcult to explain this difference
in the localization of apoptosis, but it is possible that differences
in the relative levels of mutant Comp expression between these two
models might inﬂuence the location of dysregulated apoptosis.
Based on our recent ﬁndings in the PSACH and MED mouse
models of Comp T585M [Pirog-Garcia et al., 2007] and Matn3
V194D [Leighton et al., 2007; Nundlall et al., 2010] mutations, we
HUMAN MUTATION, Vol. 33, No. 1, 218–231, 2012 227Figure5. Peroxiredoxin2isconsistentlydownregulatedinmutantmiceandacellculturemodelofPSACH.A:Proteinextractedfromthexiphoid
cartilage of 3-week-old wild-type (wt) and mutant (mut/mut) mice were analyzed by SDS-PAGE and Western blotting using an antibody against
PRDX2 (∼22 kDa). B: Densitometry analysis on the Western blots conﬁrmed that PRDX2 expression is reduced in the cartilage of mutant mice
(mut/mut) compared to wild-type animals (wt). C: Cell lysates from HT1080 cells transfected with GFP alone (GFP), GFP-COMP wild-type (WT), and
GFP-COMP mutant (MUT) were obtained either 48 or 72 hr after conﬂuence and analyzed by SDS-PAGE and Western blotting using an antibody
against PRDX2 (∼22 kDa) and normalized to β actin (∼42 kDa). D: Densitometry analysis on the Western blots conﬁrmed that PRDX2 expression
is reduced in cells transfected with the mutant protein compared to those transfected with the wild-type protein. E: Reduced PRDX2 expression in
mutant mice cartilage was also conﬁrmed by IHC on the tibial growth plates of 3-week-old mice. PRDX2 appears to be expressed by hypertrophic
chondrocytes in the growth plate of wild-type mice, while its expression is much fainter in the same zone of the mutant mice growth plate. wt,
wild-type mice; mut/mut, homozygous for D469del; VIF, vascular invasion front; Hz, hypertrophic zone; Pz, proliferative zone; ∗P < 0.05; ∗∗P < 0.005;
∗∗∗P < 0.001.
hypothesized that the expression of Comp D469del would cause
ER stress and a UPR. However, qRT-PCR and Western blot anal-
ysis both failed to reveal any increases in the relative expression
of key chaperone proteins at 5 days and 3 weeks of age (Table 1),
which was conﬁrmed by extensive microarray studies performed at
newborn and 5 days of age (Supp. Table S1 and S2). This is the
ﬁrst study to unequivocally establish the relative expression lev-
els of chaperone proteins in PSACH chondrocytes and to establish
that there is no conventional UPR due to the expression of mutant
COMP D469del. Previous studies using patient cartilage or cul-
tured patient chondrocytes have shown that mutant COMP is asso-
ciated with various chaperone proteins, such as CRT, PDI, Grp94,
Erp72,andGrp78/BiP,indistendedcisternaeoftherER,bothinvivo
and in vitro [Hecht et al., 2001; Vranka et al., 2001]. Furthermore,
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control chondrocytes demonstrated that CRT, Grp94, and Erp72
were directly associated with normal COMP, which was conﬁrmed
by Flourescence Resonance Energy Transfer (FRET) [Hecht et al.,
2001]. However, all of the previous studies on patient samples did
not determine quantitatively the relative expression levels of these
chaperone proteins and it is likely that their localization to the ER,
and association with mutant COMP and other retained ECM pro-
teins, is an indirect result of protein accumulation in the ER and
the fact that they are all ER resident proteins. This observation is
supported by IHC staining for PDI, BiP and Grp78, which show no
differences in the localization and relative amounts of these three
chaperonesinmicethatarewild-typeormutantforD469delCOMP
(Supp. Fig. S7). Finally, we also determined that there was no in-
creasedphosphorylationofeIF2α,akeymediatoroftheUPR,orany
increaseintherelativeexpressionofCHOP,animportantapoptosis-
associated downstream target of prolonged UPR (Table 1). Taken
together these data suggest that the expression of mutant COMP is
inducing apoptosis that is independent of a conventional UPR.
A consistent ﬁnding in all three knock-in mouse models of
PSACH and MED is a signiﬁcant reduction in chondrocyte prolif-
eration and the increased and/or spatially dysregulated apoptosis in
the cartilage growth plate [Leighton et al., 2007; Pirog-Garcia et al.,
2007]. The effects of the Comp D469del mutation on chondrocyte
proliferation and apoptosis was more pronounced than in our pre-
viously published models, which is consistent with the more severe
phenotype caused by the COMP p.D469del mutation in PSACH
patients.Thesedetrimentalalterationstochondrocyteproliferation
and survival are therefore likely to be key factors in the initiation
and progression of PSACH and MED. However, the speciﬁc genetic
pathways leading to reduced proliferation and apoptosis are clearly
different depending on the mutated gene and/or the speciﬁc muta-
tion. For example, our previous studies have demonstrated that the
expression of Matn3 V194D and Comp T585M cause ER stress that
results in a conventional UPR characterized by the upregulation of
various chaperone proteins [Leighton et al., 2007; Nundlall et al.,
2010; Pirog-Garcia et al., 2007], which is clearly not the case for
Comp D469del (Supp. Table S1 and S2).
In the case of Comp T585M, the UPR appears sufﬁcient for the
correct folding and secretion of mutant COMP, however, either the
UPR itself or the antimorphic effect of mutant COMP in the ECM
initiates CHOP-mediated apoptosis [Pirog-Garcia et al., 2007]. In
contrast, the UPR is not capable of mediating the correct folding
and secretion of the majority of mutant matrilin-3 (V194D), which
appears to accumulate in the rER of chondrocytes and eventually
leading to dysregulated apoptosis [Leighton et al., 2007]. However,
unlike Comp T585M, this is not CHOP-mediated and the speciﬁc
geneticpathwaysthatresultinapoptosisremainunresolved[Nund-
lall et al., 2010]. Finally, we show in this study that the expression
of Comp D469del results in signiﬁcantly increased apoptosis that
is independent of both a conventional UPR and CHOP-mediated
apoptosis. It is interesting to note that the COMP p. T585M muta-
tion is generally accepted to result in a phenotype that is deﬁned as
either mild PSACH or severe MED [Briggs et al., 1998; Song et al.,
2003], in contrast to the p.D469del mutation that always causes
the most severe form of PSACH. This difference in cellular mecha-
nisms of COMP mutations provides insight into the broad clinical
spectrum of the PSACH-MED disease group.
Our microarray studies performed at newborn and 5 days of
age have demonstrated that there are changes in the expression
levels of a variety of different genes involved in oxidative stress,
cell survival, attachment and/or migration, cell cycle arrest and
apoptosis,andNF-κBsignalling.Thesegeneexpressionchangesare
consistent with the detrimental changes in chondrocyte phenotype
thatwehaveobservedinthegrowthplate(i.e.,reducedproliferation
and increased apoptosis) and likely characterize a novel form of
chondrocyte stress that is key to the pathogenesis of PSACH in this
mouse model.
Interestingly, several recent studies have shown that UPR-
independent pathways, such as the ER overload response (EOR),
are associated with the aggregation of mutant proteins in the ER,
which induce a toxic gain of function. This is particularly the case
with the serpinopathies in which the aggregation of insoluble mis-
folded α1-antitrypsin triggers an alternative ER stress response that
is independent of the UPR and involves the activation of NF-κB
signalling [Ekeowa et al., 2010]. Recently, a role for Prdx2 in re-
ducing apoptosis through NF-κB signalling has been demonstrated
in mouse granulose cells [Yang et al., 2011], while the downreg-
ulation of PRDX2 is implicated angiotensis II-mediated podocyte
apoptosis [Hsu et al., 2011], thus providing further evidence that
these pathways are important for cell survival. In addition, we have
shown that the most highly upregulated gene in newborn chon-
drocytes was Igfbp3, while other genes (i.e., Lyve1), known to be
mediators of Igfbp3-dependant effects, were upregulated at 5 days
of age. These data suggest that Igfbp3-mediated apoptosis may play
a role in the initiation and progression of chondrocyte apoptosis
due to the expression and accumulation of COMP D469del.
In summary, we have generated a new mouse model of PSACH
and demonstrated that expression of the most common form of
mutantCOMPcausesanoveltypeofchondrocytestressthatisinde-
pendent of a conventional UPR. This interesting ﬁnding highlights
the emerging ﬁeld of UPR-independent pathways and supports al-
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